The IPO Buzz: Csquare & Standard Nuclear On the Mid-July Marquee
Two of this year’s top IPO sectors – AI data centers and nuclear energy – share the mid-July marquee. Csquare (CSQR Proposed), a data center operator in the U.S., Canada and the U.K., and Standard Nuclear (STDN Proposed), an early-stage producer of nuclear fuel, plan to go public this week and raise a total of $1.61 billion. Both IPOs – set to price mid-week – are NYSE listings.
Two small-cap deals – Tarsier Pharma of Israel and Ticketplus of Chile – are in the offing with plans to raise a total of $70.1 million.
Let’s take a look.
Data Center Play from Big D
Csquare, based in the North Dallas suburb of Coppell, Texas, is an AI data center play.
The company is offering 50 million shares at $23.00 to $27.00 to raise $1.25 billion – if priced at the $25.00 mid-point.
Morgan Stanley, TD Securities, Wells Fargo Securities. BofA Securities, BMO Capital Markets and Scotiabank are leading the joint book-running team.
Csquare owns and runs 64 data centers in 21 major metro markets in the U.S., Canada and the U.K. It delivers about 389 MW (megawatts) of sellable power capacity and more than 36,000 interconnection products to over 1,700 enterprise, network, cloud and technology customers, the prospectus said. Its U.S. data centers are near cities from coast to coast. In Canada, Csquare has three data centers near Toronto and three near Montreal. Csquare also has a data center near London.
Brookfield of Canada will still control Csquare after the IPO.
The IPO’s proceeds will be used to pay off $1.17 billion in debt.
Csquare’s revenue has grown since 2023.
Csquare is not profitable: Net loss of $150.94 million on revenue of $1.02 billion for the 12 months that ended on March 31, 2026.
Nuclear Fuel from Tennessee
Standard Nuclear (STDN Proposed), an early-stage nuclear fuel company in Oak Ridge, Tennessee, bought the assets of bankrupt Ultra Safe Nuclear in late 2024.
The company is offering 18.25 million shares at $18.00 to $21.00 to raise $355.88 million – if priced at the $19.50 mid-point.
BofA Securities and Goldman Sachs are leading the joint book-running team.
Standard Nuclear runs the only privately funded TRISO production plant in the U.S., according to the prospectus.
TRISO stands for “tristructural-isotropic” – poppyseed-sized fuel particles made from enriched uranium and coated in ceramic layers. The finished product is fuel for many types of advanced reactors.
After the IPO, Standard Nuclear founder Thomas Hendrix will still control the company.
Standard Nuclear, like most start-ups when they go public, is not profitable: Net loss of $14.97 million on revenue of $3.36 million for the 12 months that ended on March 31, 2026.
Source: https://www.iposcoop.com/the-ipo-buzz-csquare-standard-nuclear-on-the-mid-july-marquee/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

